Iothalamic Acid
This iodinated compound is used as a contrast agent for urographic, angiographic, and other diagnostic X-ray imaging procedures. It increases the opacity of blood vessels and organs on X-ray, allowing detailed visualization of anatomical structures. Various salt forms including meglumine and sodium salts are used for different applications.
Molekularmasse
613,9100 g/mol
LogP
1,90
TPSA
95,50 Ų
Lipinski-Regel der Fünf
Bestanden
Therapeutische Bereiche
Wirkmechanismus
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Pharmacokinetics (PK)
Pharmacodynamics (PD)
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
2D-Struktur
Cite this structure
Embed this structure
SMILES
CNC(=O)c1c(I)c(NC(C)=O)c(I)c(C(=O)O)c1I
InChI
InChI=1S/C11H9I3N2O4/c1-3(17)16-9-7(13)4(10(18)15-2)6(12)5(8(9)14)11(19)20/h1-2H3,(H,15,18)(H,16,17)(H,19,20)
Molecular Formula
C11H9I3N2O4
HBD / HBA
3 / 4
Rotierbare Bindungen
3
Schwere Atome
20
No targets recorded
Target interaction data is not yet available for this drug.
No interactions recorded
Drug interaction data is not yet available for this compound.
No side effects recorded
Side effect data is not yet available for this drug.
Häufig gestellte Fragen
This iodinated compound is used as a contrast agent for urographic, angiographic, and other diagnostic X-ray imaging procedures. It increases the opacity of blood vessels and organs on X-ray, allowing detailed visualization of anatomical structures. Various salt forms including meglumine and sodium salts are used for different applications.
Functions as a diagnostic agent by providing contrast enhancement or radioactive tracer activity that enables visualization of anatomical structures or physiological processes during medical imaging.
Yes, Iothalamic Acid is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.
References & Data Sources
- ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1201300. Open-access bioactivity database.
- PubChem — National Center for Biotechnology Information (NCBI). CID 3737. Chemical information database.
Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.
Medizinischer Haftungsausschluss
This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.
Embed This Widget
Add the script tag and a data attribute to embed this widget.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<div data-drugfyi="drug" data-slug="iothalamic-acid"></div>Embed via iframe for maximum compatibility.
<iframe src="https://drugfyi.com/iframe/drug/iothalamic-acid/" width="420" height="400" frameborder="0" style="border:0;border-radius:10px;max-width:100%" loading="lazy"></iframe>Paste this URL in WordPress, Medium, or any oEmbed-compatible platform.
https://drugfyi.com/drug/iothalamic-acid/Add a dynamic SVG badge to your README or docs.
[](https://drugfyi.com/drug/iothalamic-acid/)Use the native HTML custom element.
<script src="https://cdn.jsdelivr.net/npm/drugfyi-embed@1/dist/embed.min.js" defer></script>
<drugfyi-drug slug="iothalamic-acid"></drugfyi-drug>